MyFinsight
Home
Blog
About
Contact
knsa: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$30,290K
Inventory
$41,396K
Accounts receivable, net
$51,742K
Short-term investments
$177,244K
Cash and cash
equivalents
$174,858K
Deferred tax assets
$201,287K
Intangible asset, net
$15,500K
Other long-term
assets
$8,288K
Operating lease
right-of-use assets
$10,073K
Property and equipment,
net
$1,655K
Total current assets
$475,530K
Total assets
$712,333K
Total liabilities and
shareholders' equity
$712,333K
Total shareholders'
equity
$535,383K
Total liabilities
$176,950K
Accumulated deficit
-$476,337K
Accumulated other
comprehensive loss
-$155K
Additional paid-in capital
$1,011,854K
Other long-term
liabilities
$14,525K
Non-current operating lease
liabilities
$7,022K
Non-current deferred
revenue
$31,811K
Total current
liabilities
$123,592K
Ordinary shares
value-Common Class B1
$4K
Ordinary shares
value-Common Class A1
$4K
Ordinary shares
value-Common Class B
$1K
Ordinary shares
value-Common Class A
$12K
Other current
liabilities
$20,523K
Operating lease
liabilities
$2,696K
Accrued expenses
$30,941K
Accrued collaboration
expenses
$63,282K
Accounts payable
$6,150K
Back
Back
Balance Sheet
source: myfinsight.com
Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA)